Form 8-K - Current report:
SEC Accession No. 0001104659-25-057335
Filing Date
2025-06-06
Accepted
2025-06-06 16:15:19
Documents
16
Period of Report
2025-06-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517308d1_8k.htm   iXBRL 8-K 49190
2 EXHIBIT 2.3 tm2517308d1_ex2-3.htm EX-2.3 64829
3 EXHIBIT 23.1 tm2517308d1_ex23-1.htm EX-23.1 2140
4 EXHIBIT 99.1 tm2517308d1_ex99-1.htm EX-99.1 10026
8 GRAPHIC tm2517308d1_ex99-1img001.jpg GRAPHIC 2969
  Complete submission text file 0001104659-25-057335.txt   313572

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20250605.xsd EX-101.SCH 3035
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20250605_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20250605_pre.xml EX-101.PRE 22371
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2517308d1_8k_htm.xml XML 3345
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 251030841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)